📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tamoxifen- and Mifepristone-Inducible Versions of CRISPR Effectors, Cas9 and Cpf1 (2018)

First Author: Dominguez-Monedero A

Attributed to: SynthSys-Mammalian: Edinburgh Mammalian Synthetic Biology Research Centre funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acssynbio.8b00145

PubMed Identifier: 30138555

Publication URI: http://europepmc.org/abstract/MED/30138555

Type: Journal Article/Review

Parent Publication: ACS Synthetic Biology

Issue: 9

ISSN: 2161-5063